Jun 17, 2025
Оfftopic Community
Оfftopic Community
Forums
New posts
Search forums
What's new
Featured content
New posts
New media
New media comments
New resources
New profile posts
Latest activity
Media
New media
New comments
Search media
Resources
Latest reviews
Search resources
Members
Current visitors
New profile posts
Search profile posts
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Forums
Information & News
RSS News
Health and Fitness
Intravenous Administration Of Endometrial Regenerative Cells (ERC) Induces Benefit In
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="tD33NAt" data-source="post: 2142254" data-attributes="member: 124445"><p>Medistem Inc. (PINKSHEETS: MEDS) reported today a recent publication in the peer reviewed journal International Archives of Medicine describing a 74 year old heart failure patient treated with the company's endometrial regenerative cell (ERC) product in November 2007. The patient's ejection fraction, meaning the heart's pumping activity, increased from 25-30% pre-treatment to 40% in June of 2008. The increase was maintained when the patient was re-examined in August 2008 and October 2009... <a href="http://feedads.g.doubleclick.net/~a/W0nXAsl2TfBaS8ubaKWzgU6KKGw/0/da" target="_blank"><img src="http://feedads.g.doubleclick.net/~a/W0nXAsl2TfBaS8ubaKWzgU6KKGw/0/di" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></a></p><p><a href="http://feedads.g.doubleclick.net/~a/W0nXAsl2TfBaS8ubaKWzgU6KKGw/1/da" target="_blank"><img src="http://feedads.g.doubleclick.net/~a/W0nXAsl2TfBaS8ubaKWzgU6KKGw/1/di" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></a></p><p></p><p><img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/1ZnC4k0Xkxk" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></p><p></p><p><a href="http://feedproxy.google.com/~r/mnt/healthnews/~3/1ZnC4k0Xkxk/3BtY" target="_blank">More...</a></p></blockquote><p></p>
[QUOTE="tD33NAt, post: 2142254, member: 124445"] Medistem Inc. (PINKSHEETS: MEDS) reported today a recent publication in the peer reviewed journal International Archives of Medicine describing a 74 year old heart failure patient treated with the company's endometrial regenerative cell (ERC) product in November 2007. The patient's ejection fraction, meaning the heart's pumping activity, increased from 25-30% pre-treatment to 40% in June of 2008. The increase was maintained when the patient was re-examined in August 2008 and October 2009... [URL="http://feedads.g.doubleclick.net/~a/W0nXAsl2TfBaS8ubaKWzgU6KKGw/0/da"][IMG]http://feedads.g.doubleclick.net/~a/W0nXAsl2TfBaS8ubaKWzgU6KKGw/0/di[/IMG][/URL] [URL="http://feedads.g.doubleclick.net/~a/W0nXAsl2TfBaS8ubaKWzgU6KKGw/1/da"][IMG]http://feedads.g.doubleclick.net/~a/W0nXAsl2TfBaS8ubaKWzgU6KKGw/1/di[/IMG][/URL] [IMG]http://feeds.feedburner.com/~r/mnt/healthnews/~4/1ZnC4k0Xkxk[/IMG] [url=http://feedproxy.google.com/~r/mnt/healthnews/~3/1ZnC4k0Xkxk/3BtY]More...[/url] [/QUOTE]
Insert quotes…
Name
Verification
Please enable JavaScript to continue.
Loading…
Post reply
Top